[Immediate tasks and the potentials of conducting immunotherapy of malignant neoplasms].

This work sums up the immunological studies performed clinically and delineates the trends of further investigations in active non-specific, specific and passive immunotherapy associated with other methods of the treatment--irradiation, surgery, chemotherapy. There are offered 4 phases of the clinical study on the immunological effect on normalization of the cellular and humoral immunity responses in oncological patients: phase I--selecting of the dosage, phase II--studying of the effectiveness of immunostimulation, phase III--a detailed comparative study of new chemical drugs, phase IV--estimating the effectiveness of different schemes of immunotherapy including the combination treatment of oncological patients.